Statistics
Publications
9
Citations
347
H-Index
9
Active since
2021
Dengyuan Hao is an author at Chinese Academy of Sciences specializing in nanomedicine, cancer nanomedicine, and pharmacy.
Publications per year
2021–2023
9
9
Hypoxia-Activated PEGylated Paclitaxel Prodrug Nanoparticles for Potentiated Chemotherapy
Dengyuan Hao, Qian Meng, Bowen Jiang et al. · ACS Nano · 2022 · 85 citations
Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
Xiujuan Xiang, Xuan Feng, Shaojin Lu et al. · Exploration · 2022 · 82 citations · Full text
Medicine, Oncology, Pharmacology +17
A Paclitaxel Prodrug with Copper Depletion for Combined Therapy toward Triple-Negative Breast Cancer
Dengyuan Hao, Qian Meng, Chaonan Li et al. · ACS Nano · 2023 · 47 citations
Pharmacy, Oncology, Pharmacology +17
1–5 of 9